Iridex Corp (IRIX) Stock Price, Quote & News

Company Profile

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems th...

Industry: Medical Devices

Sector: Healthcare

Phone: 650 940 4700

Fax: 650 940 4710

Website: www.iridex.com

Address:

1212 Terra Bella Avenue, Mountain View, United States

deerix Jul. 2 at 3:40 PM

$IRIX added some at 0.92

0 · Reply

investingworlds Jun. 28 at 5:16 PM

$IRIX what do you all think of the amended change in the strike price of options from $1.40 to $0.94? Never seen an amendment like rhat before.

1 · Reply

StudBull Jun. 26 at 5:43 PM

$IRIX Anyone have any idea why this stock is tanking?

2 · Reply

StudBull Jun. 24 at 1:20 PM

$IRIX https://www.stocktitan.net/news/IRIX/iridex-announces-first-patient-enrolled-in-an-independent-landmark-t2ilwbrgc6wt.html

0 · Reply

Thestocktraderhubzee Jun. 24 at 11:18 AM

$IRIX Iridex-Backed DAME Trial Begins Enrollment In UK To Investigate Subthreshold MicroPulse Laser In DME Treatment Pathway

0 · Reply

deerix Jun. 18 at 1:42 PM

$IRIX buying here

0 · Reply

StudBull Jun. 15 at 7:44 PM

$IRIX CEO Patrick Mercer steps up and buys another 250 shares

1 · Reply

StudBull Jun. 13 at 6:46 PM

$IRIX Director Will Moore buys another 30K shares

0 · Reply

StudBull Jun. 12 at 2:22 PM

$IRIX Romeo still buying

0 · Reply

StudBull Jun. 10 at 8:13 PM

$IRIX compared to Romeo’s heroics, the country boy CEO’s one token stock purchase seems deficient and not much of a confidence builder

2 · Reply

Iridex Announces First Patient Enrolled in an Independent Landmark Investigator-Led UK Study Evaluating MicroPulse® Technology as an Adjunct to anti-VEGF Therapy for Diabetic Macular Edema

May 13, 2025, 9:05 PM EDT - 7 weeks ago

IRIDEX Corporation, Inc. (IRIX) Q1 2025 Earnings Call Transcript

May 13, 2025, 4:05 PM EDT - 7 weeks ago

Iridex Reports First Quarter 2025 Financial Results

May 1, 2025, 6:00 PM EDT - 2 months ago

IRIDEX Changes Course

Apr 30, 2025, 4:05 PM EDT - 2 months ago

Iridex to Report First Quarter 2025 Financial Results on May 13, 2025

Apr 16, 2025, 7:11 PM EDT - 2 months ago

IRIDEX Corporation (IRIX) Strategic Vision Conference Call (Transcript)

Apr 9, 2025, 4:05 PM EDT - 3 months ago

Iridex to Host Strategic Vision Call on April 16, 2025

Mar 27, 2025, 6:03 PM EDT - 3 months ago

IRIDEX Corporation (IRIX) Q4 2024 Earnings Call Transcript

Mar 27, 2025, 4:05 PM EDT - 3 months ago

Iridex Reports Fourth Quarter and Full Year 2024 Financial Results

Mar 19, 2025, 9:15 AM EDT - 3 months ago

Iridex Announces Strategic Investment in the Company

Mar 14, 2025, 7:00 AM EDT - 4 months ago

Iridex Comments on Recent Stock Price Volatility

Mar 13, 2025, 5:00 PM EDT - 4 months ago

Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025

Dec 18, 2024, 4:05 PM EST - 7 months ago

Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management

Nov 19, 2024, 8:14 AM EST - 8 months ago

Iridex Comments on Changing Glaucoma Reimbursement Landscape

Nov 16, 2024, 3:53 PM EST - 8 months ago

IRIDEX Corporation (IRIX) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 4:05 PM EST - 8 months ago

Iridex to Report Third Quarter 2024 Financial Results on November 12, 2024

Oct 3, 2024, 4:05 PM EDT - 9 months ago

Iridex Appoints Patrick Mercer as Chief Executive Officer

Aug 26, 2024, 11:16 AM EDT - 11 months ago

Iridex Frustrates, But Expect A Transaction By Year-End

Aug 10, 2024, 4:23 PM EDT - 11 months ago

IRIDEX Corporation (IRIX) Q2 2024 Earnings Call Transcript

May 17, 2024, 3:27 PM EDT - 1 year ago

IRIDEX Corporation (IRIX) Q1 2024 Earnings Call Transcript

May 14, 2024, 4:05 PM EDT - 1 year ago

Iridex Reports First Quarter 2024 Financial Results

Mar 28, 2024, 7:12 PM EDT - 1 year ago

Iridex's Strategic Review Process Should Bear Fruit 'Soon'

Mar 26, 2024, 7:30 PM EDT - 1 year ago

IRIDEX Corporation (IRIX) Q4 2023 Earnings Call Transcript

Mar 26, 2024, 4:05 PM EDT - 1 year ago

Iridex Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 20, 2024, 4:05 PM EDT - 1 year ago

Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024

Jan 24, 2024, 8:00 AM EST - 1 year ago

Iridex Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust

Jan 11, 2024, 6:45 PM EST - 1 year ago

Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma

Dec 28, 2023, 6:00 PM EST - 1 year ago

Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted Cyclophotocoagulation

Nov 27, 2023, 9:00 AM EST - 1 year ago

Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of Cyclophotocoagulation

Nov 14, 2023, 4:21 PM EST - 1 year ago

Iridex Reports Third Quarter 2023 Financial Results and Business Update

Nov 13, 2023, 9:00 AM EST - 1 year ago

Iridex to Host Third Quarter Financial Results Conference Call on November 14, 2023

Nov 2, 2023, 6:11 AM EDT - 1 year ago

Iridex Reimbursement Chaos Presents Buying Opportunity

Oct 26, 2023, 4:22 PM EDT - 1 year ago

Iridex to Report Third Quarter Financial Results on November 14, 2023

Oct 4, 2023, 5:04 AM EDT - 1 year ago

Iridex: The Whole Is Less Than The Sum Of The Parts

Aug 29, 2023, 4:05 PM EDT - 2 years ago

Iridex Announces Strategic Review to Unlock Shareholder Value

Aug 10, 2023, 8:33 PM EDT - 2 years ago

IRIDEX Corporation (IRIX) Q2 2023 Earnings Call Transcript

Apr 27, 2023, 4:05 PM EDT - 2 years ago

Iridex to Report First Quarter Financial Results on May 11, 2023

Mar 9, 2023, 10:12 PM EST - 2 years ago

IRIDEX Corporation (IRIX) Q4 2022 Earnings Call Transcript

Mar 9, 2023, 4:05 PM EST - 2 years ago

Iridex Reports Fourth Quarter and Full Year 2022 Financial Results

Mar 7, 2023, 4:05 PM EST - 2 years ago

Iridex to Present at the 35th Annual Roth Conference

Mar 2, 2023, 9:00 AM EST - 2 years ago

Iridex Introduces New Research and Showcases Five Events at the AGS Meeting

Feb 23, 2023, 4:05 PM EST - 2 years ago

Iridex to Report Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023

Jan 10, 2023, 4:05 PM EST - 2 years ago

Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2022

Dec 6, 2022, 5:07 PM EST - 2 years ago

Iridex to Participate in Fireside Chat with Stifel Equity Research

Nov 10, 2022, 10:11 PM EST - 2 years ago

IRIDEX Corporation (IRIX) Q3 2022 Earnings Call Transcript

Sep 29, 2022, 4:05 PM EDT - 3 years ago

Iridex Showcases its Non-Incisional Treatments for Glaucoma, Introduces Sweep Management Software, and Hosts 8 Physician Presentations at AAO 2022

Aug 18, 2022, 4:05 PM EDT - 3 years ago

Iridex to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase

Aug 15, 2022, 6:55 PM EDT - 3 years ago

IRIDEX Corporation's (IRIX) CEO David Bruce on Q2 2022 Results - Earnings Call Transcript

Aug 15, 2022, 4:05 PM EDT - 3 years ago

Iridex Announces Second Quarter 2022 Financial Results

Aug 1, 2022, 4:05 PM EDT - 3 years ago

Iridex to Report Second Quarter 2022 Financial Results on August 15, 2022

deerix Jul. 2 at 3:40 PM

$IRIX added some at 0.92

0 · Reply

investingworlds Jun. 28 at 5:16 PM

$IRIX what do you all think of the amended change in the strike price of options from $1.40 to $0.94? Never seen an amendment like rhat before.

1 · Reply

StudBull Jun. 26 at 5:43 PM

$IRIX Anyone have any idea why this stock is tanking?

2 · Reply

StudBull Jun. 24 at 1:20 PM

$IRIX https://www.stocktitan.net/news/IRIX/iridex-announces-first-patient-enrolled-in-an-independent-landmark-t2ilwbrgc6wt.html

0 · Reply

Thestocktraderhubzee Jun. 24 at 11:18 AM

$IRIX Iridex-Backed DAME Trial Begins Enrollment In UK To Investigate Subthreshold MicroPulse Laser In DME Treatment Pathway

0 · Reply

deerix Jun. 18 at 1:42 PM

$IRIX buying here

0 · Reply

StudBull Jun. 15 at 7:44 PM

$IRIX CEO Patrick Mercer steps up and buys another 250 shares

1 · Reply

StudBull Jun. 13 at 6:46 PM

$IRIX Director Will Moore buys another 30K shares

0 · Reply

StudBull Jun. 12 at 2:22 PM

$IRIX Romeo still buying

0 · Reply

StudBull Jun. 10 at 8:13 PM

$IRIX compared to Romeo’s heroics, the country boy CEO’s one token stock purchase seems deficient and not much of a confidence builder

2 · Reply

StudBull Jun. 8 at 3:04 PM

$IRIX 6/6 Form 4 showing the Romeo of Iridex in beast mode buying another 1500 shares.

1 · Reply

MGeronimo Jun. 4 at 2:26 AM

$IRIX INSIDER BUYING THIS IS GOING TO A NEW 52 week high

0 · Reply

10baggerPete Jun. 3 at 7:47 PM

$IRIX soon to break 1000 watchers OMG .... Romeo, Romeo , wherefore arth thou Romeo, it's been a few days since you bought. Has your love reached its limit? How about some news about a plan!

1 · Reply

10baggerPete May. 24 at 1:44 PM

$IRIX Romeo is bleeding!

2 · Reply

StudBull May. 9 at 1:24 PM

$IRIX Romeo buys another 100 shares. Dude is hitting from the men's tee

2 · Reply

10baggerPete May. 6 at 3:15 PM

$IRIX another insider buy from Romeo ... he's emptied the piggy bank and turned the sofa upside down for his latest 200 share purchase.

1 · Reply

StudBull May. 2 at 11:54 AM

$IRIX “Despite initial disappointment with the result of the strategic review, I believe IRIDEX shares are undervalued at $1.30/share, with potential for 170-200% returns within 12–24 months.” https://seekingalpha.com/article/4780803-iridex-changes-course

0 · Reply

StudBull May. 1 at 2:19 PM

$IRIX Director William Moore buys another 20,000 shares in $1.21-1.24 price range, after paying $1.05-1.08 to buy 20,000 shares last week. Very nice to see multiple insiders buying after the pre-announcement, and in advance of the ER and call on 5/13

0 · Reply

builderup Apr. 29 at 11:19 AM

$IRIX close 👀 on this one $NLSP starting to look attractive

0 · Reply

10baggerPete Apr. 29 at 12:10 AM

$IRIX Romeo appears to be love struck with his daily buying

0 · Reply

CEOBuysDisclosures Apr. 28 at 11:25 PM

$IRIX CEO purchased 7,546 shares at $1.29 for a total of $9,758. Mercer Patrick now owns 400,790 shares. https://ceo-buys.com

0 · Reply

CEOBuysDisclosures Apr. 28 at 11:20 PM

$IRIX CEO purchased 7,546 shares at $1.29 for a total of $9,758. Mercer Patrick now owns 400,790 shares. https://ceo-buys.com

0 · Reply

Market Cap	15.61M
Revenue (ttm)	48.67M
Net Income (ttm)	-8.91M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-18.31%
Debt to Equity Ratio	0.53

Volume	5,400
Avg Vol	76,476
Day's Range	N/A - N/A
Shares Out	16.79M
Stochastic %K	55%
Beta	0.57
Analysts	Strong Buy
Price Target	$2.00